Keratosis, Actinic: all 369 studies

Page 2 of 4. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.

• ACT01 in Combination With Comp01-04 in Patients With Actinic KeratosisCompletedNCT02126670Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic KeratosesCompletedNCT02120898Phase 3Results posted
• Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic KeratosisCompletedNCT02120456Phase 1/2Results posted
• Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic KeratosisCompletedNCT02100813Phase 1/2Results posted
• Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic KeratosisCompletedNCT01998984Phase 2Results posted
• Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic KeratosisCompletedNCT01986920Phase 1/2Results posted
• Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)CompletedNCT01966120Phase 3Results posted
• A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic KeratosisCompletedNCT01962987Phase 3Results posted
• Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%CompletedNCT01926496Phase 4Results posted
• A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic KeratosisCompletedNCT01922050Phase 1/2Results posted
• Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)CompletedNCT01893203Phase 4Results posted
• Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic KeratosesCompletedNCT01821391Phase 3Results posted
• Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic KeratosisCompletedNCT01820260Phase 1/2Results posted
• The Use of Microneedles in Photodynamic TherapyCompletedNCT01812837Not applicableResults posted
• Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.TerminatedNCT01806961Results posted
• A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/ExtremitiesCompletedNCT01787383Phase 3Results posted
• Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic KeratosisCompletedNCT01686152Phase 3Results posted
• Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and ScalpCompletedNCT01600014Phase 3Results posted
• A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and ScalpCompletedNCT01541553Phase 3Results posted
• Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted PatientsTerminatedNCT01532453Phase 3Results posted
• Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin DiseaseTerminatedNCT01525329Phase 3Results posted
• Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)CompletedNCT01475955Phase 2Results posted
• Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic KeratosesCompletedNCT01475071Phase 3Results posted
• Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)CompletedNCT01458587Phase 2Results posted
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal MicroscopyCompletedNCT01449513Phase 1Results posted
• Treatment of Keratosis Pilaris With 810 nm Diode LaserCompletedNCT01281644Not applicableResults posted
• Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic TherapyTerminatedNCT01203878Phase 4Results posted
• Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic KeratosesCompletedNCT01053000Not applicableResults posted
• Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)CompletedNCT01000636Phase 4Results posted
• Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic KeratosisCompletedNCT00948428Phase 3Results posted
• Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective StudyTerminatedNCT00944216Phase 4Results posted
• A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head LocationsCompletedNCT00942604Phase 3Results posted
• Short Incubation Methylaminolevulinate Photodynamic Therapy Without OcclusionCompletedNCT00926952Phase 3Results posted
• A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)CompletedNCT00916006Phase 3Results posted
• A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)CompletedNCT00915551Phase 3Results posted
• Safety and Effectiveness Study of Actinic Keratosis Treatment Following CryosurgeryCompletedNCT00894647Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic KeratosisCompletedNCT00852137Phase 2Results posted
• Bioequivalence Study of Two Imiquimod Cream 5%CompletedNCT00828568Phase 1Results posted
• The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic KeratosesCompletedNCT00786994Phase 2Results posted
• Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic KeratosesCompletedNCT00774787Phase 4Results posted
• A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head LocationsCompletedNCT00742391Phase 3Results posted
• Dermatosis Papulosa NigraCompletedNCT00710203Not applicableResults posted
• A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)CompletedNCT00700063Phase 2Results posted
• Measuring Adherence To Topical 5-Fluorouracil in a Clinic PopulationCompletedNCT00696488Phase 4Results posted
• Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post CryotherapyCompletedNCT00695578Phase 4Results posted
• Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One YearCompletedNCT00668733Results posted
• Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)CompletedNCT00605176Phase 3Results posted
• Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)CompletedNCT00603798Phase 3Results posted
• Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic KeratosisTerminatedNCT00524485Not applicableResults posted
• Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin CancerCompletedNCT00472459Phase 3Results posted
• Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and ScalpCompletedNCT00304239Phase 3Results posted
• Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic KeratosisCompletedNCT00116649Phase 4Results posted
• Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.CompletedNCT07428941
• Evaluate RLS-1496 Topical Cream for Actinic KeratosisActive, not recruitingNCT07340697Phase 1/2
• Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AKCompletedNCT07290959Not applicable
• Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and PhotodamageCompletedNCT07053852Phase 1
• Comparison of Nicotinamide Treatments for Actinic KeratosisCompletedNCT07049068Phase 1
• Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full FaceActive, not recruitingNCT06745999Phase 4
• Carac & PDT Combination in the Treatment Of Actinic KeratosesCompletedNCT06712381Phase 1/2
• Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses TreatmentCompletedNCT06507644Not applicable
• Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic KeratosisCompletedNCT06319794Phase 2
• Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis PilarisActive, not recruitingNCT06032078Not applicable
• Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the HandsWithdrawnNCT06026358Phase 4
• OCT and Invasion in Cutaneous Skin LesionsCompletedNCT06014697
• Patient Decision Aid for the Treatment of Actinic KeratosisActive, not recruitingNCT06008171Not applicable
• The Influence of an E-learning Program on Recognition of Actinic KeratosisActive, not recruitingNCT05987553
• High- and Low-risk Actinic Keratosis Referrals to Secondary CareActive, not recruitingNCT05976061
• Implementation of Actinic Keratosis Guideline Among General Practitioners.Active, not recruitingNCT05976048
• Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic KeratosisCompletedNCT05937529Not applicable
• Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic KeratosesCompletedNCT05923060Phase 2
• Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the FaceCompletedNCT05900258Phase 4
• Gene and Protein Expression Profiles After Treatment of Actinic KeratosesStatus unknownNCT05740969Phase 2
• ADL-PDT Under Routine Clinical Conditions in Patients With Actinic KeratosisCompletedNCT05725213
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant RecipientsActive, not recruitingNCT05699603Phase 2
• Laser to Aid in Treatment of Keratosis Pilaris on ArmsStatus unknownNCT05666011Not applicable
• Microwave Treatment for Actinic KeratosisActive, not recruitingNCT05636800Not applicable
• Development and Validation of an Investigator Global Assessment Score for Keratosis PilarisStatus unknownNCT05535517
• Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®CompletedNCT05522036Not applicable
• UV Sensor in Patients With Actinic KeratosisCompletedNCT05481073
• New Treatments for Actinic Keratoses of the ScalpActive, not recruitingNCT05456334Not applicable
• A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or ScalpActive, not recruitingNCT05387525Phase 4
• Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper ExtremitiesStatus unknownNCT05359419Phase 4
• A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty SkinCompletedNCT05356572Not applicable
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or ScalpCompletedNCT05231044Phase 3
• Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic KeratosisActive, not recruitingNCT05202860Phase 2
• Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AKStatus unknownNCT05164393Phase 1/2
• MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic KeratosisStatus unknownNCT05152407Not applicable
• Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic KeratosisActive, not recruitingNCT05136144Phase 2
• Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic KeratosisCompletedNCT05078827Phase 3
• Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical TrialCompletedNCT04875026Phase 4
• Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant RecipientsCompletedNCT04843553Early Phase 1
• Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% CreamCompletedNCT04842422Phase 4
• HRQoL Keratinocyte CarcinomasStatus unknownNCT04814953
• Comparing Immune Responses to Topical ImiquimodTerminatedNCT04809662
• Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis PilarisCompletedNCT04797663Phase 4
• Pain Management During a Photodynamic Therapy Session on the Vertex for Actinic Keratosis: Tumescent Anesthesia InterestStatus unknownNCT04779255Not applicable
• Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageTerminatedNCT04688749
• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnNCT04642287Phase 2
• 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic KeratosisCompletedNCT04552327Phase 3
• Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic KeratosesCompletedNCT04527653Not applicable

← Keratosis, Actinic overview